| Nonalcoholic fatty liver disease and the metabolic syndrome G Marchesini, R Marzocchi, F Agostini, E Bugianesi Current opinion in lipidology 16 (4), 421-427, 2005 | 523 | 2005 |
| Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey L Pironi, D Konrad, C Brandt, F Joly, G Wanten, F Agostini, C Chambrier, ... Clinical nutrition 37 (2), 728-738, 2018 | 155 | 2018 |
| Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control F Di Pierro, N Villanova, F Agostini, R Marzocchi, V Soverini, ... Diabetes, metabolic syndrome and obesity: targets and therapy, 213-217, 2012 | 123 | 2012 |
| Epidemiology of nosocomial infection in 125 Italian intensive care units P Malacarne, D Boccalatte, A Acquarolo, F Agostini, A Anghileri, ... Minerva anestesiologica 76 (1), 13, 2010 | 107 | 2010 |
| Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure F Joly, J Baxter, M Staun, DG Kelly, YL Hwa, O Corcos, A De Francesco, ... Clinical nutrition 37 (4), 1415-1422, 2018 | 100 | 2018 |
| Home artificial nutrition in palliative care cancer patients: Impact on survival and performance status E Ruggeri, M Giannantonio, F Agostini, R Ostan, L Pironi, R Pannuti Clinical nutrition 39 (11), 3346-3353, 2020 | 77 | 2020 |
| Assessment of quality of life on home parenteral nutrition and after intestinal transplantation using treatment‐specific questionnaires L Pironi, JP Baxter, A Lauro, M Guidetti, F Agostini, C Zanfi, AD Pinna American Journal of Transplantation 12, S60-S66, 2012 | 74 | 2012 |
| Update on nutritional supplementation with branched-chain amino acids G Bianchi, R Marzocchi, F Agostini, G Marchesini Current Opinion in Clinical Nutrition & Metabolic Care 8 (1), 83-87, 2005 | 71 | 2005 |
| Assessment of intestinal failure associated liver disease according to different diagnostic criteria AS Sasdelli, F Agostini, C Pazzeschi, M Guidetti, S Lal, L Pironi Clinical Nutrition 38 (3), 1198-1205, 2019 | 61 | 2019 |
| Growth factor release from platelet concentrates: analytic quantification and characterization for clinical applications C Durante, F Agostini, L Abbruzzese, R T. Toffola, S Zanolin, C Suine, ... Vox Sanguinis 105 (2), 129-136, 2013 | 53 | 2013 |
| Pressure control ventilation and minitracheotomy in treating severe flail chest trauma C Gregoretti, G Foti, F Beltrame, PM Giugiaro, P Biolino, L Burbi, M Turello, ... Intensive care medicine 21, 1054-1056, 1995 | 48 | 1995 |
| Update on branched-chain amino acid supplementation in liver diseases G Bianchi, R Marzocchi, F Agostini, G Marchesini Current opinion in gastroenterology 21 (2), 197-200, 2005 | 43 | 2005 |
| Prion protein accumulation in lipid rafts of mouse aging brain F Agostini, CG Dotti, A Pérez-Cañamás, MD Ledesma, F Benetti, ... PLoS One 8 (9), e74244, 2013 | 38 | 2013 |
| Renal function in patients on long-term home parenteral nutrition and in intestinal transplant recipients L Pironi, A Lauro, V Soverini, C Zanfi, F Agostini, M Guidetti, C Pazzeschi, ... Nutrition 30 (9), 1011-1014, 2014 | 37 | 2014 |
| the treatment of fatty liver disease associated with the metabolic syndrome G Marchesini, S Natale, R Manini, F Agostini Alimentary pharmacology & therapeutics 22, 37-39, 2005 | 32 | 2005 |
| Functional lipidomics in patients on home parenteral nutrition: effect of lipid emulsions L Pironi, M Guidetti, O Verrastro, C Iacona, F Agostini, C Pazzeschi, ... World Journal of Gastroenterology 23 (25), 4604, 2017 | 31 | 2017 |
| Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus S Benvegnù, P Roncaglia, F Agostini, C Casalone, C Corona, ... Physiological genomics 43 (12), 711-725, 2011 | 31 | 2011 |
| Treatment of non-alcoholic fatty liver disease with focus on emerging drugs G Marchesini, S Moscatiello, F Agostini, N Villanova, D Festi Expert opinion on emerging drugs 16 (1), 121-136, 2011 | 30 | 2011 |
| Long term cryopreservation in 5% DMSO maintains unchanged CD34+ cells viability and allows satisfactory hematological engraftment after peripheral blood stem … L Abbruzzese, F Agostini, C Durante, RT Toffola, M Rupolo, FM Rossi, ... Vox sanguinis 105 (1), 77-80, 2013 | 26 | 2013 |
| Home artificial nutrition in advanced cancer patients E Ruggeri, F Agostini, L Fettucciari, M Giannantonio, L Pironi, F Pannuti Tumori Journal 99 (2), 218-224, 2013 | 22 | 2013 |
Caterina PazzeschiDietista, Ospedale S.Orsola Malpighi, Università di Bologna在 aosp.bo.it 的电子邮件经过验证
